DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Influence of Synacthen Infusion on the Results of Adrenal Venous Sampling in Patient With Primary Aldosteronism

Information source: Charles University, Czech Republic
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Primary Aldosteronism

Intervention: Synacthen infusion during adrenal venous sampling (Drug)

Phase: Phase 4

Status: Recruiting

Sponsored by: Charles University, Czech Republic

Official(s) and/or principal investigator(s):
Jiri Ceral, MD, Study Chair, Affiliation: University Hospital Hradec Kralove

Overall contact:
Miroslav Solar, MD, Phone: +420495834739, Email: miroslav.solar@fnhk.cz

Summary

The project is aimed to determine the value of synacthen infusion on the results of adrenal venous sampling in patients examined for primary aldosteronism

Clinical Details

Official title: Influence of Synacthen Infusion on the Results of Adrenal Venous Sampling in Patient With Primary Aldosteronism

Study design: Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Primary outcome: To verify whether Synacthen infusion may influence the results of adrenal venous sampling in patients with primary aldosteronism

Detailed description: We aim to compare the results of adrenal venous sampling performed without and during synacthen infusion.

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria: Confirmed primary aldosteronism Exclusion Criteria: Inability to undergo unilateral adrenalectomy

Locations and Contacts

Miroslav Solar, MD, Phone: +420495834739, Email: miroslav.solar@fnhk.cz

University Hospital Hradec Kralove, Hradec Kralove 50005, Czech Republic; Recruiting
Miroslav Solar, MD, Phone: +420495834739, Email: miroslav.solar@fnhk.cz
Additional Information

Starting date: March 2011
Last updated: April 28, 2014

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017